Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 20,747 | 19,127 | 36,281 | 13,917 | 24,939 |
| Cost of Goods | 10,103 | 9,623 | 9,815 | 7,366 | 10,433 |
| Gross Profit | 10,644 | 9,504 | 26,466 | 6,551 | 14,506 |
| Operating Expenses | 28,817 | 28,692 | 28,343 | 4,303 | 26,297 |
| Operating Income | -18,070 | -18,565 | -1,062 | 2,614 | -11,358 |
| Interest Expense | 795 | 779 | 773 | 741 | 715 |
| Other Income | 366 | -8 | 426 | -52 | 138 |
| Pre-tax Income | -18,499 | -19,352 | -1,409 | 1,821 | -11,935 |
| Net Income Continuous | -18,499 | -19,352 | -1,409 | 1,821 | -11,935 |
| Net Income | $-18,499 | $-19,352 | $-1,409 | $1,821 | $-11,935 |
| EPS Basic Total Ops | -0.21 | -0.23 | -0.01 | 0.02 | -0.16 |
| EPS Basic Continuous Ops | -0.21 | -0.23 | -0.01 | 0.02 | -0.16 |
| EPS Diluted Total Ops | -0.21 | -0.23 | -0.01 | 0.02 | -0.16 |
| EPS Diluted Continuous Ops | -0.21 | -0.23 | -0.01 | 0.02 | -0.16 |
| EBITDA(a) | $-16,815 | $-17,449 | $179 | $3,708 | $-10,187 |